AGRN and cancer: Our study aimed to evaluate agrin levels in patients with newly diagnosed, unresectable hepatobiliary cancers compared to healthy controls without a history of such cancers and to assess the associations between agrin levels and various factors, including smoking, alcohol consumption, viral hepatitis, cirrhosis, performance status, AFP levels, and other malignancy characteristics.